home All News open_in_new Full Article

REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures

– Funding agreement contemplates a conversion formula with a potential 30% premium upon conversion and positions the Company for growth, and accelerated advancement of its clinical pipeline programs, CYB003 and CYB004 – TORONTO — Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental […]


today 10 h. ago attach_file Economics

attach_file Culture
attach_file Culture
attach_file Economics
attach_file Other
attach_file Culture
attach_file Politics
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Economics
attach_file Culture
attach_file Other
attach_file Economics
attach_file Economics
attach_file Events
attach_file Other
attach_file Economics


ID: 1678554225
Add Watch Country

arrow_drop_down